Form 4 for CNMD CONMED Corp
Accepted 2023-05-02 00:00:00 ET · period of report 2023-04-28 · accession 0001127602-23-014082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-02 | 2023-04-28 | CNMD | Berge Terence M | VP-Corp. Ctrl | M - OptEx | $72.98 | +18.7K | 3,804 | New | +$1.36M |
| DM | 2023-05-02 | 2023-04-28 | CNMD | Berge Terence M | VP-Corp. Ctrl | S - Sale+OE | $126.74 | -18.7K | 11.5K | -62% | -$2.37M |
| DM | 2023-05-02 | 2023-04-28 | CNMD | Berge Terence M | VP-Corp. Ctrl | M - OptEx | $0.00 | -18.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-28 | M | A | 5,100 | $97.69 | 19,704 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-28 | S | D | 2,800 | $127.44 | 16,904 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.25 to $127.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 3 | Common | Common Stock | 2023-04-28 | S | D | 5,400 | $126.42 | 6,104 | D | — | — | |
| 4 | Common | Common Stock | 2023-04-28 | M | A | 5,400 | $78.76 | 14,604 | D | — | — | |
| 5 | Common | Common Stock | 2023-04-28 | M | A | 5,400 | $59.96 | 9,204 | D | — | — | |
| 6 | Common | Common Stock | 2023-04-28 | S | D | 5,100 | $126.65 | 1,004 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.54 to $126.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 7 | Common | Common Stock | 2023-04-28 | S | D | 5,400 | $126.78 | 11,504 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.60 to $127.23. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 8 | Common | Common Stock | 2023-04-28 | M | A | 2,800 | $41.93 | 3,804 | D | — | — | |
| 9 | Derivative | Options To Purchase Common Stock | 2023-04-28 | M | D | 5,100 | $0.00 | 5,100 | D | $97.69 · — to 2030-03-02 | 5,100 Common Stock | (F5) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 10 | Derivative | Options To Purchase Common Stock | 2023-04-28 | M | D | 5,400 | $0.00 | 2,700 | D | $78.76 · — to 2029-03-01 | 5,400 Common Stock | (F5) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 11 | Derivative | Options To Purchase Common Stock | 2023-04-28 | M | D | 2,800 | $0.00 | 0 | D | $41.93 · — to 2031-03-01 | 2,800 Common Stock | (F4) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| 12 | Derivative | Options To Purchase Common Stock | 2023-04-28 | M | D | 5,400 | $0.00 | 0 | D | $59.96 · — to 2028-03-01 | 5,400 Common Stock | (F4) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |